Loading clinical trials...
Loading clinical trials...
Insulin Leakage and Pain Perception in IDDM Children or Adolescents, Where the Injections Are Performed With NovoFine™ 6 x 0.30 mm Needles and NovoFine® 8 x 0.30 mm Needles: An Open, Randomized, Two-period Cross-over, Multi-centre, Phase IIIb Trial at 4 Centres
Conditions
Interventions
NovoFine® needle 6 mm
NovoFine® needle 8 mm
Locations
1
Italy
Novo Nordisk Investigational Site
Chieti, Italy
Start Date
January 20, 1998
Primary Completion Date
July 27, 1998
Completion Date
July 27, 1998
Last Updated
August 7, 2018
NCT00001987
NCT07051005
NCT07296484
NCT07480161
NCT05119179
NCT06671587
Lead Sponsor
Novo Nordisk A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions